{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:50:21Z","timestamp":1793451021449,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/inf.0b013e3182615615","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T10:50:52Z","timestamp":1338979852000},"page":"1016-1021","source":"Crossref","is-referenced-by-count":47,"title":["Evolving Picture of Invasive Pneumococcal Disease in Massachusetts Children"],"prefix":"10.1097","volume":"31","author":[{"given":"Inci","family":"Yildirim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbie","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine K.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen I.","family":"Pelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210202","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/JCM.44.3.999-1017.2006","article-title":"Active Bacterial Core Surveillance Team. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002.","volume":"44","author":"Beall","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R3-6-20210202","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":"Active Bacterial Core Surveillance (ABCs)Emerging Infections Program Network. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.","volume":"285","author":"Robinson","year":"2001","journal-title":"JAMA"},{"key":"R5-6-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-6-20210202","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"R7-6-20210202","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2008-3099","article-title":"Continued impact of pneumococcal conjugate vaccine on carriage in young children.","volume":"124","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"key":"R8-6-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vaccine.2010.10.032","article-title":"Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease.","volume":"29","author":"Yildirim","year":"2010","journal-title":"Vaccine"},{"key":"R9-6-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Active Bacterial Core SurveillanceEmerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"R10-6-20210202","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3181c15471","article-title":"Massachusetts Department of Public Health. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.","volume":"29","author":"Hsu","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R11-6-20210202","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","article-title":"Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.","volume":"26","author":"Pelton","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R12-6-20210202","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/j.vaccine.2010.04.020","article-title":"Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development.","volume":"28","author":"Reinert","year":"2010","journal-title":"Vaccine"},{"key":"R14-6-20210202","first-page":"144","article-title":"Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introductioneight states, 1998-2005.","volume":"57","author":"Reingold","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R19-6-20210202","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"key":"R20-6-20210202","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1016\/j.vaccine.2010.06.008","article-title":"Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use.","volume":"28","author":"Aguiar","year":"2010","journal-title":"Vaccine"},{"key":"R21-6-20210202","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s10096-011-1251-9","article-title":"ORP Ile de France Ouest. Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine.","volume":"30","author":"Grall","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R22-6-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.","volume":"46","author":"Munoz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R23-6-20210202","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1086\/498043","article-title":"Active Bacterial Core Surveillance Team. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.","volume":"192","author":"Pai","year":"2005","journal-title":"J Infect Dis"},{"key":"R25-6-20210202","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/01.inf.0000235684.89728.38","article-title":"Molecular typing of pneumococci causing parapneumonic empyema in Spanish children using multilocus sequence typing directly on pleural fluid samples.","volume":"25","author":"Obando","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R27-6-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes.","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R28-6-20210202","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2006.09.009","article-title":"The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease.","volume":"25","author":"Hausdorff","year":"2007","journal-title":"Vaccine"},{"key":"R29-6-20210202","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/JCM.01200-09","article-title":"Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah.","volume":"48","author":"Byington","year":"2010","journal-title":"J Clin Microbiol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e3182615615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:31:43Z","timestamp":1620955903000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201210000-00006"}},"subtitle":["A Comparison of Disease in 2007\u20132009 With Earlier Periods"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3182615615","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}